Back to today’s briefing

Story perspectives

Senate Committee Demands Safer Generic Drugs Amid Concerns

10/28/2025

23 2

Summary

Story summary

The Senate Special Committee on Aging proposed changes to improve generic drug safety.
The committee criticized the U.S. Food and Drug Administration (FDA) for allowing more than 20 foreign facilities, mainly in India, to supply medicines.
They called for better drug tracking and more rigorous testing.
They highlighted a study linking Indian-made generics to higher hospitalizations and adverse events than U.S. products.

1 of 1

Story summary

The Senate Special Committee on Aging proposed changes to improve generic drug safety.
The committee criticized the U.S. Food and Drug Administration (FDA) for allowing more than 20 foreign facilities, mainly in India, to supply medicines.
They called for better drug tracking and more rigorous testing.
They highlighted a study linking Indian-made generics to higher hospitalizations and adverse events than U.S. products.